Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Hospice Care Market

ID: MRFR/HC/41109-HCR
200 Pages
Satyendra Maurya
Last Updated: April 24, 2026

Hospice Care Market Research Report: Size, Share, Trend Analysis By Service Type (Routine Home Care, Continuous Home Care, Inpatient Respite Care, General Inpatient Care), By Care Setting (Home Care, Hospice Facilities, Nursing Homes, Assisted Living Facilities), By Patient Condition (Cancer, Cardiovascular Diseases, Neurological Disorders, Chronic Respiratory Diseases), By End Userss (Patients, Family Members, Healthcare Providers, Hospice Organizations), By Payer Type (Medicare, Medicaid, Private Insurance, Out-of-Pocket) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Hospice Care Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Service Type (USD Billion) | |
      1. 4.1.1 Routine Home Care | |
      2. 4.1.2 Continuous Home Care | |
      3. 4.1.3 Inpatient Respite Care | |
      4. 4.1.4 General Inpatient Care |
    2. 4.2 Healthcare, BY Care Setting (USD Billion) | |
      1. 4.2.1 Home Care | |
      2. 4.2.2 Hospice Facilities | |
      3. 4.2.3 Nursing Homes | |
      4. 4.2.4 Assisted Living Facilities |
    3. 4.3 Healthcare, BY Patient Condition (USD Billion) | |
      1. 4.3.1 Cancer | |
      2. 4.3.2 Cardiovascular Diseases | |
      3. 4.3.3 Neurological Disorders | |
      4. 4.3.4 Chronic Respiratory Diseases |
    4. 4.4 Healthcare, BY End Users (USD Billion) | |
      1. 4.4.1 Patients | |
      2. 4.4.2 Family Members | |
      3. 4.4.3 Healthcare Providers | |
      4. 4.4.4 Hospice Organizations |
    5. 4.5 Healthcare, BY Payer Type (USD Billion) | |
      1. 4.5.1 Medicare | |
      2. 4.5.2 Medicaid | |
      3. 4.5.3 Private Insurance | |
      4. 4.5.4 Out-of-Pocket |
    6. 4.6 Healthcare, BY Region (USD Billion) | |
      1. 4.6.1 North America | | |
        1. 4.6.1.1 US | | |
        2. 4.6.1.2 Canada | |
      2. 4.6.2 Europe | | |
        1. 4.6.2.1 Germany | | |
        2. 4.6.2.2 UK | | |
        3. 4.6.2.3 France | | |
        4. 4.6.2.4 Russia | | |
        5. 4.6.2.5 Italy | | |
        6. 4.6.2.6 Spain | | |
        7. 4.6.2.7 Rest of Europe | |
      3. 4.6.3 APAC | | |
        1. 4.6.3.1 China | | |
        2. 4.6.3.2 India | | |
        3. 4.6.3.3 Japan | | |
        4. 4.6.3.4 South Korea | | |
        5. 4.6.3.5 Malaysia | | |
        6. 4.6.3.6 Thailand | | |
        7. 4.6.3.7 Indonesia | | |
        8. 4.6.3.8 Rest of APAC | |
      4. 4.6.4 South America | | |
        1. 4.6.4.1 Brazil | | |
        2. 4.6.4.2 Mexico | | |
        3. 4.6.4.3 Argentina | | |
        4. 4.6.4.4 Rest of South America | |
      5. 4.6.5 MEA | | |
        1. 4.6.5.1 GCC Countries | | |
        2. 4.6.5.2 South Africa | | |
        3. 4.6.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 VITAS Healthcare (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Amedisys Inc (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 LHC Group (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Brookdale Senior Living (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Kindred Healthcare (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Curo Health Services (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Seasons Hospice & Palliative Care (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Compassus (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Heartland Hospice (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies | |
      10. 5.2.10 Visiting Angels (US) | | |
        1. 5.2.10.1 Financial Overview | | |
        2. 5.2.10.2 Products Offered | | |
        3. 5.2.10.3 Key Developments | | |
        4. 5.2.10.4 SWOT Analysis | | |
        5. 5.2.10.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY SERVICE TYPE |
    7. 6.4 US MARKET ANALYSIS BY CARE SETTING |
    8. 6.5 US MARKET ANALYSIS BY PATIENT CONDITION |
    9. 6.6 US MARKET ANALYSIS BY END USERS |
    10. 6.7 US MARKET ANALYSIS BY PAYER TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY SERVICE TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY CARE SETTING |
    13. 6.10 CANADA MARKET ANALYSIS BY PATIENT CONDITION |
    14. 6.11 CANADA MARKET ANALYSIS BY END USERS |
    15. 6.12 CANADA MARKET ANALYSIS BY PAYER TYPE |
    16. 6.13 EUROPE MARKET ANALYSIS |
    17. 6.14 GERMANY MARKET ANALYSIS BY SERVICE TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY CARE SETTING |
    19. 6.16 GERMANY MARKET ANALYSIS BY PATIENT CONDITION |
    20. 6.17 GERMANY MARKET ANALYSIS BY END USERS |
    21. 6.18 GERMANY MARKET ANALYSIS BY PAYER TYPE |
    22. 6.19 UK MARKET ANALYSIS BY SERVICE TYPE |
    23. 6.20 UK MARKET ANALYSIS BY CARE SETTING |
    24. 6.21 UK MARKET ANALYSIS BY PATIENT CONDITION |
    25. 6.22 UK MARKET ANALYSIS BY END USERS |
    26. 6.23 UK MARKET ANALYSIS BY PAYER TYPE |
    27. 6.24 FRANCE MARKET ANALYSIS BY SERVICE TYPE |
    28. 6.25 FRANCE MARKET ANALYSIS BY CARE SETTING |
    29. 6.26 FRANCE MARKET ANALYSIS BY PATIENT CONDITION |
    30. 6.27 FRANCE MARKET ANALYSIS BY END USERS |
    31. 6.28 FRANCE MARKET ANALYSIS BY PAYER TYPE |
    32. 6.29 RUSSIA MARKET ANALYSIS BY SERVICE TYPE |
    33. 6.30 RUSSIA MARKET ANALYSIS BY CARE SETTING |
    34. 6.31 RUSSIA MARKET ANALYSIS BY PATIENT CONDITION |
    35. 6.32 RUSSIA MARKET ANALYSIS BY END USERS |
    36. 6.33 RUSSIA MARKET ANALYSIS BY PAYER TYPE |
    37. 6.34 ITALY MARKET ANALYSIS BY SERVICE TYPE |
    38. 6.35 ITALY MARKET ANALYSIS BY CARE SETTING |
    39. 6.36 ITALY MARKET ANALYSIS BY PATIENT CONDITION |
    40. 6.37 ITALY MARKET ANALYSIS BY END USERS |
    41. 6.38 ITALY MARKET ANALYSIS BY PAYER TYPE |
    42. 6.39 SPAIN MARKET ANALYSIS BY SERVICE TYPE |
    43. 6.40 SPAIN MARKET ANALYSIS BY CARE SETTING |
    44. 6.41 SPAIN MARKET ANALYSIS BY PATIENT CONDITION |
    45. 6.42 SPAIN MARKET ANALYSIS BY END USERS |
    46. 6.43 SPAIN MARKET ANALYSIS BY PAYER TYPE |
    47. 6.44 REST OF EUROPE MARKET ANALYSIS BY SERVICE TYPE |
    48. 6.45 REST OF EUROPE MARKET ANALYSIS BY CARE SETTING |
    49. 6.46 REST OF EUROPE MARKET ANALYSIS BY PATIENT CONDITION |
    50. 6.47 REST OF EUROPE MARKET ANALYSIS BY END USERS |
    51. 6.48 REST OF EUROPE MARKET ANALYSIS BY PAYER TYPE |
    52. 6.49 APAC MARKET ANALYSIS |
    53. 6.50 CHINA MARKET ANALYSIS BY SERVICE TYPE |
    54. 6.51 CHINA MARKET ANALYSIS BY CARE SETTING |
    55. 6.52 CHINA MARKET ANALYSIS BY PATIENT CONDITION |
    56. 6.53 CHINA MARKET ANALYSIS BY END USERS |
    57. 6.54 CHINA MARKET ANALYSIS BY PAYER TYPE |
    58. 6.55 INDIA MARKET ANALYSIS BY SERVICE TYPE |
    59. 6.56 INDIA MARKET ANALYSIS BY CARE SETTING |
    60. 6.57 INDIA MARKET ANALYSIS BY PATIENT CONDITION |
    61. 6.58 INDIA MARKET ANALYSIS BY END USERS |
    62. 6.59 INDIA MARKET ANALYSIS BY PAYER TYPE |
    63. 6.60 JAPAN MARKET ANALYSIS BY SERVICE TYPE |
    64. 6.61 JAPAN MARKET ANALYSIS BY CARE SETTING |
    65. 6.62 JAPAN MARKET ANALYSIS BY PATIENT CONDITION |
    66. 6.63 JAPAN MARKET ANALYSIS BY END USERS |
    67. 6.64 JAPAN MARKET ANALYSIS BY PAYER TYPE |
    68. 6.65 SOUTH KOREA MARKET ANALYSIS BY SERVICE TYPE |
    69. 6.66 SOUTH KOREA MARKET ANALYSIS BY CARE SETTING |
    70. 6.67 SOUTH KOREA MARKET ANALYSIS BY PATIENT CONDITION |
    71. 6.68 SOUTH KOREA MARKET ANALYSIS BY END USERS |
    72. 6.69 SOUTH KOREA MARKET ANALYSIS BY PAYER TYPE |
    73. 6.70 MALAYSIA MARKET ANALYSIS BY SERVICE TYPE |
    74. 6.71 MALAYSIA MARKET ANALYSIS BY CARE SETTING |
    75. 6.72 MALAYSIA MARKET ANALYSIS BY PATIENT CONDITION |
    76. 6.73 MALAYSIA MARKET ANALYSIS BY END USERS |
    77. 6.74 MALAYSIA MARKET ANALYSIS BY PAYER TYPE |
    78. 6.75 THAILAND MARKET ANALYSIS BY SERVICE TYPE |
    79. 6.76 THAILAND MARKET ANALYSIS BY CARE SETTING |
    80. 6.77 THAILAND MARKET ANALYSIS BY PATIENT CONDITION |
    81. 6.78 THAILAND MARKET ANALYSIS BY END USERS |
    82. 6.79 THAILAND MARKET ANALYSIS BY PAYER TYPE |
    83. 6.80 INDONESIA MARKET ANALYSIS BY SERVICE TYPE |
    84. 6.81 INDONESIA MARKET ANALYSIS BY CARE SETTING |
    85. 6.82 INDONESIA MARKET ANALYSIS BY PATIENT CONDITION |
    86. 6.83 INDONESIA MARKET ANALYSIS BY END USERS |
    87. 6.84 INDONESIA MARKET ANALYSIS BY PAYER TYPE |
    88. 6.85 REST OF APAC MARKET ANALYSIS BY SERVICE TYPE |
    89. 6.86 REST OF APAC MARKET ANALYSIS BY CARE SETTING |
    90. 6.87 REST OF APAC MARKET ANALYSIS BY PATIENT CONDITION |
    91. 6.88 REST OF APAC MARKET ANALYSIS BY END USERS |
    92. 6.89 REST OF APAC MARKET ANALYSIS BY PAYER TYPE |
    93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
    94. 6.91 BRAZIL MARKET ANALYSIS BY SERVICE TYPE |
    95. 6.92 BRAZIL MARKET ANALYSIS BY CARE SETTING |
    96. 6.93 BRAZIL MARKET ANALYSIS BY PATIENT CONDITION |
    97. 6.94 BRAZIL MARKET ANALYSIS BY END USERS |
    98. 6.95 BRAZIL MARKET ANALYSIS BY PAYER TYPE |
    99. 6.96 MEXICO MARKET ANALYSIS BY SERVICE TYPE |
    100. 6.97 MEXICO MARKET ANALYSIS BY CARE SETTING |
    101. 6.98 MEXICO MARKET ANALYSIS BY PATIENT CONDITION |
    102. 6.99 MEXICO MARKET ANALYSIS BY END USERS |
    103. 6.100 MEXICO MARKET ANALYSIS BY PAYER TYPE |
    104. 6.101 ARGENTINA MARKET ANALYSIS BY SERVICE TYPE |
    105. 6.102 ARGENTINA MARKET ANALYSIS BY CARE SETTING |
    106. 6.103 ARGENTINA MARKET ANALYSIS BY PATIENT CONDITION |
    107. 6.104 ARGENTINA MARKET ANALYSIS BY END USERS |
    108. 6.105 ARGENTINA MARKET ANALYSIS BY PAYER TYPE |
    109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE |
    110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY CARE SETTING |
    111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT CONDITION |
    112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USERS |
    113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PAYER TYPE |
    114. 6.111 MEA MARKET ANALYSIS |
    115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY SERVICE TYPE |
    116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY CARE SETTING |
    117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY PATIENT CONDITION |
    118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY END USERS |
    119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PAYER TYPE |
    120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY SERVICE TYPE |
    121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY CARE SETTING |
    122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY PATIENT CONDITION |
    123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY END USERS |
    124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PAYER TYPE |
    125. 6.122 REST OF MEA MARKET ANALYSIS BY SERVICE TYPE |
    126. 6.123 REST OF MEA MARKET ANALYSIS BY CARE SETTING |
    127. 6.124 REST OF MEA MARKET ANALYSIS BY PATIENT CONDITION |
    128. 6.125 REST OF MEA MARKET ANALYSIS BY END USERS |
    129. 6.126 REST OF MEA MARKET ANALYSIS BY PAYER TYPE |
    130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
    131. 6.128 RESEARCH PROCESS OF MRFR |
    132. 6.129 DRO ANALYSIS OF HEALTHCARE |
    133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
    136. 6.133 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE) |
    137. 6.134 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion) |
    138. 6.135 HEALTHCARE, BY CARE SETTING, 2024 (% SHARE) |
    139. 6.136 HEALTHCARE, BY CARE SETTING, 2024 TO 2035 (USD Billion) |
    140. 6.137 HEALTHCARE, BY PATIENT CONDITION, 2024 (% SHARE) |
    141. 6.138 HEALTHCARE, BY PATIENT CONDITION, 2024 TO 2035 (USD Billion) |
    142. 6.139 HEALTHCARE, BY END USERS, 2024 (% SHARE) |
    143. 6.140 HEALTHCARE, BY END USERS, 2024 TO 2035 (USD Billion) |
    144. 6.141 HEALTHCARE, BY PAYER TYPE, 2024 (% SHARE) |
    145. 6.142 HEALTHCARE, BY PAYER TYPE, 2024 TO 2035 (USD Billion) |
    146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    147. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.2.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.3.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.4.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.5.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.6.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.7.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.8.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.9.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.10.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.11.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.12.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.13.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.14.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.15.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.16.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.17.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.18.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.19.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.20.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.21.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.22.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.23.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.24.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.25.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.26.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.27.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.28.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.29.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY SERVICE TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY CARE SETTING, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY PATIENT CONDITION, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END USERS, 2025-2035 (USD Billion) | |
      5. 7.30.5 BY PAYER TYPE, 2025-2035 (USD Billion) |
    177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    178. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Service Type (USD Billion, 2025-2035)

  • Routine Home Care
  • Continuous Home Care
  • Inpatient Respite Care
  • General Inpatient Care

Healthcare By Care Setting (USD Billion, 2025-2035)

  • Home Care
  • Hospice Facilities
  • Nursing Homes
  • Assisted Living Facilities

Healthcare By Patient Condition (USD Billion, 2025-2035)

  • Cancer
  • Cardiovascular Diseases
  • Neurological Disorders
  • Chronic Respiratory Diseases

Healthcare By End Users (USD Billion, 2025-2035)

  • Patients
  • Family Members
  • Healthcare Providers
  • Hospice Organizations

Healthcare By Payer Type (USD Billion, 2025-2035)

  • Medicare
  • Medicaid
  • Private Insurance
  • Out-of-Pocket

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions